ArticleIndian journal of dermatology

Body Mass Index, Disease Duration and Tumor Necrosis Factor Inhibitor History Predict Reduced Ustekinumab Response in Chinese Psoriasis Patients: A Real-World Study.

Xue Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.